PhillyVoice highlighted news that the first clinical trial of a gene-editing therapy for human immunodeficiency virus type 1 (HIV) infection is now underway, thanks to a major collaborative effort between scientists at the Lewis Katz School of Medicine, including Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Microbiology, Immunology, and Inflammation, Director of the Center for Neurovirology and Gene Editing, and Director of the Comprehensive NeuroAIDS Center; and Tricia H.